يعرض 1 - 20 نتائج من 18,105 نتيجة بحث عن '"POLY(ADP-ribose) polymerase"', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 1
    Academic Journal

    المصدر: Investigative & Clinical Urology. Jan2025, Vol. 66 Issue 1, p56-66. 15p.

    مصطلحات موضوعية: *POLY(ADP-ribose) polymerase, *G proteins, *CELL cycle, *DOCETAXEL, *DNA repair

  2. 2
    Academic Journal

    المؤلفون: Pae, Sookhee1 (AUTHOR), Sedukhina, Anna S.1,2 (AUTHOR), Sugiyama, Runa3 (AUTHOR), Atanacio, Sarah J.2 (AUTHOR), Ohara, Tatsuru4 (AUTHOR), Ishii, Masato4 (AUTHOR), Minagawa, Kimino5 (AUTHOR), Akichjev, Romaan2,6 (AUTHOR), Go, Fumie2,7 (AUTHOR), Chandankeri, Zayan2,7 (AUTHOR), Janjetic, Zoran M. M.2,7 (AUTHOR), Sato, Eri2 (AUTHOR), Yamaura, Ayako2 (AUTHOR), Meguro, Rei2,8 (AUTHOR), Palanisamy, Kishore2,9 (AUTHOR), Maeda, Ichiro10,11 (AUTHOR), Takeuchi, Osamu12 (AUTHOR), Suzuki, Nao4 (AUTHOR), Yudo, Kazuo1 (AUTHOR), Bernal, Juan A.13 (AUTHOR)

    المصدر: Scientific Reports. 12/28/2024, Vol. 14 Issue 1, p1-11. 11p.

  3. 3
    Academic Journal

    المؤلفون: Langelier, Marie-France1 (AUTHOR), Mirhasan, Manija1 (AUTHOR), Gilbert, Karine2 (AUTHOR), Sverzhinksy, Aleksandr1 (AUTHOR), Furtos, Alexandra2 (AUTHOR), Pascal, John M.1 (AUTHOR) john.pascal@umontreal.ca

    المصدر: Molecular Cell. Dec2024, Vol. 84 Issue 24, p4758-47477. 42720p.

  4. 4
    Academic Journal

    المؤلفون: Srkalovic, Gordan1,2 (AUTHOR), Rothe, Michael3 (AUTHOR), Mangat, Pam K.3 (AUTHOR) TAPURPublications@asco.org, Garrett-Mayer, Elizabeth3 (AUTHOR), Ahn, Eugene R.4 (AUTHOR), Brouse, Gregory5 (AUTHOR), Chan, John6 (AUTHOR), Mehmi, Inderjit7 (AUTHOR), Khalil, Maya8 (AUTHOR), Duvivier, Herbert L.9 (AUTHOR), Gaba, Anu10 (AUTHOR), Leuva, Harshraj11 (AUTHOR), Thota, Ramya12 (AUTHOR), Yost, Kathleen J.13 (AUTHOR), Grantham, Gina N.3 (AUTHOR), Gregory, Abigail3 (AUTHOR), Hinshaw, Dominique C.3 (AUTHOR), Halabi, Susan14 (AUTHOR), Schilsky, Richard L.3 (AUTHOR)

    المصدر: JCO Precision Oncology. 12/1/2024, Vol. 8, p1-13. 13p.

  5. 5
    Academic Journal
  6. 6
    Academic Journal

    المؤلفون: Vuong, Billy1 (AUTHOR), Fang, Yuhua1 (AUTHOR), Tranmer, Geoffrey K.1 (AUTHOR) Geoffrey.Tranmer@umanitoba.ca

    المصدر: Canadian Journal of Chemistry. 2024, Vol. 102 Issue 12, p865-874. 10p.

  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal

    المؤلفون: Ghorai, Atanu1,2 (AUTHOR), Saha, Soumajit1 (AUTHOR), Rao, Basuthkar J.1,3 (AUTHOR) bjrao@uohyd.ac.in

    المصدر: Genes & Environment. 9/18/2024, Vol. 46 Issue 1, p1-12. 12p.

  12. 12
    Academic Journal

    المؤلفون: Ouararhni, Khalid1 (AUTHOR), Mietton, Flore2 (AUTHOR), Sabir, Jamal S. M.3,4 (AUTHOR), Ibrahim, Abdulkhaleg1,5 (AUTHOR), Molla, Annie2 (AUTHOR), Albheyri, Raed S.3,4 (AUTHOR), Zari, Ali T.3,4 (AUTHOR), Bahieldin, Ahmed3,4 (AUTHOR), Menoni, Hervé2 (AUTHOR), Bronner, Christian1 (AUTHOR), Dimitrov, Stefan2,6 (AUTHOR) stefan.dimitrov@univ-grenoble-alpes.fr, Hamiche, Ali1 (AUTHOR) hamiche@igbmc.fr

    المصدر: BMC Biology. 9/2/2024, Vol. 22 Issue 1, p1-14. 14p.

  13. 13
    Academic Journal
  14. 14
    Report

    المصدر: APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

  15. 15
    Report

    المؤلفون: NRG Oncology

    المصدر: A Randomized Trial of Selumetinib and Olaparib or Selumetinib Alone in Patients With Recurrent or Persistent RAS Pathway Mutant Ovarian and Endometrial Cancers: A ComboMATCH Treatment Trial

  16. 16
    Report

    المصدر: A Phase 2 Study of Olaparib and Cediranib for the Treatment of Recurrent Ovarian Cancer

  17. 17
    Report

    المصدر: EFFORT: Efficacy of AZD1775 in Parp Resistance; A Randomized 2-Arm, Non-Comparative Phase 2 Study of AZD1775 Alone or AZD1775 and Olaparib in Women With Ovarian Cancer Who Have Progressed During PARP Inhibition

  18. 18
    Report

    المصدر: Biomarker Directed Trial of Temozolomide and PARP Inhibition in Relapsed SCLC

  19. 19
    Report

    المصدر: Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients With Germline BRCA1 or BRCA2 Mutations

  20. 20
    Report

    المؤلفون: NRG Oncology

    المصدر: A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5363 (Capivasertib) in Women With Recurrent, Persistent or Metastatic Endometrial Cancer.: A Platform Trial for Women With Recurrent or Persistent Endometrial Cancer